Clinical Scorecard: Innovative Use of Contrast-Enhanced Ultrasound for Imaging Prostate Cancer
At a Glance
Category
Detail
Condition
Prostate cancer (PCa)
Key Mechanisms
Detection of prostate cancer through imaging of tissue stiffness, vascularity, and perfusion using ultrasound techniques including contrast-enhanced ultrasound (CEUS)
Target Population
Men at risk for or suspected of having prostate cancer
Care Setting
Urology clinics, radiology departments, and settings where prostate imaging and biopsy guidance are performed
Key Highlights
Standard grayscale transrectal ultrasound (TRUS) has low accuracy for prostate cancer detection (11–35% visibility of malignancies).
Contrast-enhanced ultrasound (CEUS) improves visualization of microvascular changes and low blood flow in prostate cancer lesions.
Computerized analysis methods (C-TRUS, Histoscanning) and elastography show promise but require further validation.
Guideline-Based Recommendations
Diagnosis
Use TRUS primarily for prostate volume measurement and biopsy guidance due to limited sensitivity in cancer detection.
Consider contrast-enhanced ultrasound to improve detection of microvascular changes associated with prostate cancer.
Employ computerized analysis systems cautiously as current diagnostic accuracy is insufficient for routine clinical use.
Management
Use elastography-guided biopsies to potentially reduce the number of biopsy cores while maintaining detection rates.
Incorporate CEUS to target biopsies more accurately by identifying areas of increased microvessel density.
Monitoring & Follow-up
Monitor prostate lesions with imaging modalities that assess vascularity and perfusion changes over time.
Use CEUS to evaluate treatment response by assessing changes in tumor perfusion.
Risks
Recognize that standard ultrasound techniques have limitations in sensitivity and specificity, potentially leading to missed diagnoses.
Be aware of user dependency and learning curve associated with ultrasound imaging techniques.
Patient & Prescribing Data
Men undergoing evaluation for suspected prostate cancer, including those with previous negative biopsies
CEUS-guided biopsies may increase cancer detection rates compared to repeated systematic biopsies; elastography may reduce biopsy numbers without compromising detection.
Clinical Best Practices
Combine multiple imaging modalities (e.g., T2-weighted MRI with dynamic contrast-enhanced MRI) for improved staging accuracy.
Use CEUS to enhance detection of low blood flow in microvasculature not visible with color or power Doppler alone.
Apply computerized analysis tools as adjuncts but not as standalone diagnostic methods until further validation.
Train operators thoroughly to mitigate user dependency and improve ultrasound imaging quality.
